Journal
ACTA HISTOCHEMICA
Volume 116, Issue 8, Pages 1367-1373Publisher
ELSEVIER GMBH
DOI: 10.1016/j.acthis.2014.08.009
Keywords
Human breast cancer; Prognostic markers; Rho-associated protein kinase 1; Metalloproteinase-9
Categories
Funding
- FAPESP/Brazil - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/13154-0]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/13154-0] Funding Source: FAPESP
Ask authors/readers for more resources
Breast cancer is the most common tumor in women and it has high mortality mainly due to the occurrence of tumor metastasis. Both the processes of cell migration and anchorage to the substrate are essential for the development of metastasis. These processes occur by rearrangements of the actin cytoskeleton, regulated by Rho-associated protein kinase 1 (ROCK-1). The degradation of the extracellular matrix, influenced by metalloproteinase 9 (MMP-9) also exerts greater cell invasiveness. The present study evaluated the ROCK-1 and MMP-9 proteins using an immunohistochemical method through the selection of invasive ductal breast carcinoma. The protein expression was correlated to clinicopathological parameters and overall survival of the patients. High expression of the ROCK-1 protein was correlated statistically to the status of lymph nodes (p = 0.007) and showed variable expression in different clinical stages of the tumor. MMP-9 showed a strong immunostaining in patients with metastasis that had died, whereas there was no marker in normal breast tissues. In addition, 46.6% of patients classified as poor prognosis showed high expression of ROCK-1 and MMP-9 protein and another 40.0% just showed high expression of MMP-9. Thus, the differential expression of ROCK-1 and MMP-9 proteins suggests their potential use as prognostic markers in breast cancer. (C) 2014 Elsevier GmbH. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available